AI tool to predict how cancer patients will respond to immunotherapy

Researchers from NCI's Center for Cancer Research and Memorial Sloan Kettering Cancer Center have developed an AI tool that uses routine clinical data, such as patient age and cancer type, to predict a patient’s likelihood of responding to an immune checkpoint inhibitor. Notably, the model was also able to identify patients with low tumor mutational burden who could still be treated effectively with immunotherapy. Tap for more details ...